NovalGen Ltd
R&D/Manufacturing
- Website
- https://www.novalgen.com/
- Membership category
- Corporate
Argyle House, Joel Street, Northwood, HA6 1NW, United Kingdom
NovalGen Ltd at a glance
NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
About NovalGen Ltd
NovalGen is a privately held immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. Our dedicated team of experienced scientists, physicians and professionals are passionate about building a pipeline of disruptive and differentiated bispecific antibody products that are tailored to the needs of the patient enabling life-enhancing treatments for people with hematologic and solid tumors. The company’s lead program, NVG-111, is an ROR1 targeting bispecific antibody T cell engager using our breakthrough bispecific technology which is expected to enter clinical development in H1 2021
